13F HOLDINGS REPORT
TCG Crossover Management, LLC
Quarter ended Q1 2023 · Filed February 14, 2023 · Accession 0001214659-23-002234
Total Value
$566.6M
Positions
21
Other Managers
0
Confidential Omitted
No
Holdings (21)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | IVERIC BIO INC | 46583P102 | 5,141,118 | $110.1M | 19.43% |
| 2 | MADRIGAL PHARMACEUTICALS INC | MDGL | 288,054 | $83.6M | 14.76% |
| 3 | COGENT BIOSCIENCES INC | COGT | 3,631,042 | $42.0M | 7.41% |
| 4 | CYMABAY THERAPEUTICS INC | 23257D103 | 5,905,400 | $37.0M | 6.53% |
| 5 | GERON CORP | GERN | 15,187,073 | $36.8M | 6.49% |
| 6 | SILENCE THERAPEUTICS PLC | SLNCF | 2,104,875 | $32.1M | 5.67% |
| 7 | AEROVATE THERAPEUTICS INC | 008064107 | 1,081,274 | $31.7M | 5.59% |
| 8 | VIRIDIAN THERAPEUTICS, INC | VRDN | 983,610 | $28.7M | 5.07% |
| 9 | VENTYX BIOSCIENCES, INC | 92332V107 | 787,231 | $25.8M | 4.56% |
| 10 | KALVISTA PHARMACEUTICALS, INC | KALV | 3,395,495 | $23.0M | 4.05% |
| 11 | VECTIVBIO HOLDING AG | H9060V101 | 2,333,300 | $20.2M | 3.57% |
| 12 | ACLARIS THERAPEUTICS INC | ACRS | 1,144,939 | $18.0M | 3.18% |
| 13 | KURA ONCOLOGY INC | KURA | 1,423,642 | $17.7M | 3.12% |
| 14 | IMMUNOVANT, INC | IMVT | 854,853 | $15.2M | 2.68% |
| 15 | TYRA BIOSCIENCES INC | TYRA | 1,989,103 | $15.1M | 2.67% |
| 16 | MOONLAKE IMMUNOTHERAPEUTICS | MLTX | 1,000,000 | $10.5M | 1.85% |
| 17 | ENTRADA THERAPEUTICS INC | TRDA | 584,955 | $7.9M | 1.40% |
| 18 | MERUS BV | N5749R100 | 300,000 | $4.6M | 0.82% |
| 19 | CABALETTA BIO, INC | CABA | 486,795 | $4.5M | 0.79% |
| 20 | ALPINE IMMUNE SCIENCES INC | 02083G100 | 253,069 | $1.9M | 0.33% |
| 21 | ELEVATION ONCOLOGY INC | 28623U101 | 288,390 | $273,971 | 0.05% |